Home News Page 62

News

MedImmune, AstraZeneca’s Global Biologics Research and Development Arm, Acquires Spirogen and Enteres into a...

AstraZeneca global biologics research and development arm MedImmune, has acquired Spirogen, a privately-held biotech company focused on antibody-drug conjugate...

SAFC Invests in Commercial-Scale ADC Conjugation Manufacturing and Services

SAFC® Commercial, Sigma-Aldrich Corporation's custom manufacturing services business unit, is expanding two of its manufacturing facilities in the United...

New [14C]-labelled ADCs Service Offered by Almac

In recent years the interest in antibody drug conjugates for the targeted treatment of various cancer types has grown...

Carbogen Amcis AG Makes Capital Investments in ADC – New ADC Capabilities Benefit Oncology...

Switzerland-based Carbogen Amcis announced a series of significant investments designed to enhancing its antibody drug conjugate (ADC) capabilities to...

BMS Partners Again with Ambrx, in Up-to-$112M-and-Up ADC Collaboration

Bristol-Myers Squibb (BMS) will use Ambrx’s protein medicinal technology to develop antibody drug conjugates (ADCs) for unspecified cancer indications,...

Algeta Expands Cancer Drug Collaboration with Lumiphore

Algeta will expand its three-year-old cancer drug collaboration with Lumiphore by taking an exclusive worldwide license for the latter’s...

Anti-CD22 Monomethyl Auristatin Antibody-drug Conjugate Offers Potential Treatment for Non-Hodgkins Lymphoma

Antibody-drug conjugates (ADCs) are target-specific anticancer agents consisting of cytotoxic drugs covalently linked to a monoclonal antibody. They allow specific...

CytomX’s Antibody Therapies Target Cancer, Leave Healthy Tissue Intact

Antibody technology holds promise for treating a wide array of diseases, and designing new antibodies is a hot area...

Total Antibody Quantification for MMAE-Conjugated Antibody-Drug Conjugates: Impact of Assay Format and Reagents

The use of antibody drug conjugates (ADCs) as targeted chemotherapies has successfully entered clinical practice and holds great promise....

The Analytical and Bioanalytical Technologies for Characterizing Antibody-drug Conjugates

Antibody-drug conjugates (ADCs) require multiple assays for analytical and bioanalytical characterization due to their heterogeneous and dynamic nature. These...

FEATURED RESOURCES